EAM
VYGR icon

Erste Asset Management’s Voyager Therapeutics VYGR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.44M Hold
1,116,793
0.03% 321
2025
Q1
$3.83M Buy
1,116,793
+58,415
+6% +$200K 0.05% 249
2024
Q4
$5.94M Hold
1,058,378
0.07% 223
2024
Q3
$6.19M Hold
1,058,378
0.07% 218
2024
Q2
$8.36M Hold
1,058,378
0.11% 171
2024
Q1
$9.9M Hold
1,058,378
0.13% 156
2023
Q4
$9M Hold
1,058,378
0.13% 160
2023
Q3
$8.2M Hold
1,058,378
0.14% 160
2023
Q2
$12.1M Sell
1,058,378
-30,000
-3% -$343K 0.21% 122
2023
Q1
$8.39M Sell
1,088,378
-50,000
-4% -$386K 0.16% 154
2022
Q4
$6.86M Hold
1,138,378
0.14% 163
2022
Q3
$6.76M Hold
1,138,378
0.15% 163
2022
Q2
$6.73M Sell
1,138,378
-84,522
-7% -$500K 0.15% 169
2022
Q1
$9.36M Sell
1,222,900
-40,000
-3% -$306K 0.18% 144
2021
Q4
$3.59M Buy
1,262,900
+300,000
+31% +$853K 0.06% 245
2021
Q3
$2.55M Buy
962,900
+220,000
+30% +$582K 0.05% 258
2021
Q2
$3.07M Buy
742,900
+150,000
+25% +$620K 0.06% 252
2021
Q1
$2.81M Buy
592,900
+205,000
+53% +$970K 0.07% 232
2020
Q4
$2.82M Buy
387,900
+45,000
+13% +$327K 0.08% 235
2020
Q3
$3.68M Hold
342,900
0.13% 180
2020
Q2
$4.3M Buy
342,900
+9,000
+3% +$113K 0.17% 141
2020
Q1
$3.03M Buy
333,900
+13,000
+4% +$118K 0.18% 144
2019
Q4
$4.33M Buy
320,900
+15,000
+5% +$203K 0.19% 125
2019
Q3
$5.26M Buy
305,900
+7,000
+2% +$120K 0.28% 102
2019
Q2
$8.08M Hold
298,900
0.43% 59
2019
Q1
$5.71M Buy
298,900
+240,000
+407% +$4.59M 0.32% 84
2018
Q4
$529K Buy
+58,900
New +$529K 0.04% 304